Patent · US Active

Antiviral agent

US9492501B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 4, 2010
Grant dateNov 15, 2016
Priority date—
Expiry dateNov 5, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/56988
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention describes the use of a composition including or constituted by at least one element chosen from:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.